|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$1,577||Benefits minus costs||$6,175|
|Participants||$3,080||Benefit to cost ratio||$23.05|
|Others||$305||Chance the program will produce|
|Indirect||$1,493||benefits greater than the costs||57 %|
|Net program cost||($280)|
|Benefits minus cost||$6,175|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Alcohol use disorder
Clinical diagnosis of alcohol use disorder or symptoms measured on a validated scale.
Substance use disorder^
A non-specified alcohol or drug use disorder. Typically, a collection of different types of disorders reported by study authors.
Illicit drug use disorder
Clinical diagnosis of illicit drug use disorder or symptoms measured on a validated scale. When possible, we exclude cannabis/marijuana use disorder from this outcome.
Opioid use disorder
Clinical diagnosis of opioid use disorder or symptoms on a validated scale.
Retention and engagement in treatment or care.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Alcohol use disorder||Criminal justice system||$1||$0||$4||$1||$6|
|Labor market earnings associated with alcohol abuse or dependence||$1,221||$2,868||$0||$0||$4,089|
|Property loss associated with alcohol abuse or dependence||$0||$4||$8||$0||$12|
|Illicit drug use disorder||Health care associated with illicit drug abuse or dependence||$285||$44||$293||$143||$765|
|Mortality associated with illicit drugs||$70||$164||$0||$1,489||$1,723|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($140)||($140)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$263||2014||Present value of net program costs (in 2018 dollars)||($280)|
|Comparison costs||$0||2014||Cost range (+ or -)||10 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Ball, S.A., Martino, S., Nich, C., Frankforter, T.L., Van, H.D., Crits-Christoph, P., . . . Carroll, K.M. (2007). Site matters: Multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. Journal of Consulting and Clinical Psychology, 75 (4), 556-567.
Blondell, R.D., Frydrych, L.M., Jaanimagi, U., Ashrafioun, L., Homish, G.G., Foschio, E.M., & Bashaw, H.L. (2011). A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases, 30(2), 136-148.
Brown, J.M., & Miller, W.R. (1993). Impact of motivational interviewing on participation and outcome in residential alcoholism treatment. Psychology of Addictive Behaviors, 7(4), 211-218.
Carroll, K.M., Libby, B., Sheehan, J. & Hyland, N. (2001). Motivational interviewing to Enhance Treatment Initiation in Substance Abusers: An Effectiveness Study. The American Journal on Addictions, 10(4), 335-339.
Carroll, K.M., Ball, S.A., Nich, C., Martino, S., Frankforter, T.L., Farentinos, C., . . . Woody, G.E. (2006). Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence, 81(3), 301-312.
Carroll, K.M., Martino, S., Ball, S.A., Nich, C., Frankforter, T., Anez, L. M., . . . Farentinos, C. (2009). A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users. Journal of Consulting and Clinical Psychology, 77(5), 993-999.
Daley, D.C., Salloum, I.M., Zuckoff, A., Kirisci, L., & Thase, M.E. (1998). Increasing treatment adherence among outpatients with depression and cocaine dependence: Results of a pilot study. The American Journal of Psychiatry, 155(11), 1611-1613.
Davis, T.M., Baer, J.S., Saxon, A.J., & Kivlahan, D.R. (2003). Brief motivational feedback improves post-incarceration treatment contact among veterans with substance use disorders. Drug and Alcohol Dependence, 69(2), 197-203.
Dench, S., & Bennett, G. (2000). The impact of brief motivational intervention at the start of an outpatient day programme for alcohol dependence. Behavioral and Cognitive Psychotherapy, 28(2), 121-130.
Longshore, D., & Grills, C. (2000). Motivating illegal drug use recovery: Evidence for a culturally congruent intervention. Journal of Black Psychology, 26(3), 288-301.
Lozano, B.E., LaRowe, S.D., Smith, J.P., Tuerk, P., & Roitzsch, J. (2013). Brief motivational feedback may enhance treatment entry in veterans with comorbid substance use and psychiatric disorders. The American Journal on Addictions, 22(2), 132-135.
Martino, S., Carroll, K.M., Nich, C., & Rounsaville, B.J. (2006). A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction, 101(10), 1479-1492.
Miller, W.R., Yahne, C.E., & Tonigan, J.S. (2003). Motivational interviewing in drug abuse services: a randomized trial. Journal of Consulting and Clinical Psychology, 71(4), 754-63.
Mitcheson, L., McCambridge, J., & Byrne, S. (2007). Pilot cluster-randomised trial of adjunctive motivational interviewing to reduce crack cocaine use in clients on methadone maintenance. European Addiction Research, 13(1), 6-10.
Mullins, S.M., Suarez, M., Ondersma, S.J., & Page, M.C. (2004). The impact of motivational interviewing on substance abuse treatment retention: A randomized control trial of women involved with child welfare. Journal of Substance Abuse Treatment, 27(1), 51-58.
Nyamathi, A., Shoptaw, S., Cohen, A., Greengold, B., Nyamathi, K., Marfisee, M., de, C.V., ... Leake, B. (2010). Effect of motivational interviewing on reduction of alcohol use. Drug and Alcohol Dependence, 107(1), 23-30.
Nyamathi, A.M., Nandy, K., Greengold, B., Marfisee, M., Khalilifard, F., Cohen, A., & Leake, B. (2011). Effectiveness of intervention on improvement of drug use among methadone maintained adults. Journal of Addictive Diseases, 30(1), 6-16.
Saunders, B., Wilkinson, C., & Phillips, M. (1995). The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction, 90(3), 415-424.
Winhusen, T., Kropp, F., Babcock, D., Hague, D., Erickson, S. J., Renz, C., . . . Somoza, E. (2008). Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. Journal of Substance Abuse Treatment, 35(2), 161-173.